The Mental Health Clinical Research Center (MHCRC) is dedicated to investigating the biological basis of psychopathology. A major goal of the center is to study candidate biological markers of mental illnesses with particular attention paid to questions of disease specificity. Issues of disease specificity are critical to the validation of current nosological criteria and mechanistic hypotheses of disease pathogenesis. Several investigators with independent laboratories participate in the center. Center investigations include studies of: 1) cerebrospinal fluid and serum concentrations of neurotransmitters, neurotransmitter metabolites, and psychotropic medications; 2) highly specific pharmacological treatments to probe target neurotransmitter systems; 3) brain structure, particularly by CT and MR mapping; 4) sleep electrophysiology; 5) waking psychophysiology (i.e., event-related potentials); and 6) biostatistical methodology. Patients are admitted to the MHCRC and maintained medication-free for most protocols; parallel non-patient control data are also collected. Diagnosis, ongoing clinical assessment, treatment, statistical support, database maintenance, and quality control are core center functions. A large cross-sectional database on patients and controls has been established and is a significant resource.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH030854-16
Application #
3106969
Study Section
Special Emphasis Panel (SRCM (17))
Project Start
1977-09-29
Project End
1993-11-30
Budget Start
1992-12-01
Budget End
1993-11-30
Support Year
16
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Deshmukh, Anjali; Rosenbloom, Margaret J; De Rosa, Eve et al. (2005) Regional striatal volume abnormalities in schizophrenia: effects of comorbidity for alcoholism, recency of alcoholic drinking, and antipsychotic medication type. Schizophr Res 79:189-200
Sullivan, Edith V; Rosenbloom, Margaret J; Pfefferbaum, Adolf (2004) Balance and gait deficits in schizophrenia compounded by the comorbidity of alcoholism. Am J Psychiatry 161:751-5
Panizzon, Matthew S; Hoff, Anne L; Nordahl, Thomas E et al. (2003) Sex differences in the corpus callosum of patients with schizophrenia. Schizophr Res 62:115-22
Mathalon, Daniel H; Pfefferbaum, Adolf; Lim, Kelvin O et al. (2003) Compounded brain volume deficits in schizophrenia-alcoholism comorbidity. Arch Gen Psychiatry 60:245-52
Mathalon, Daniel H; Bennett, Amy; Askari, Nusha et al. (2003) Response-monitoring dysfunction in aging and Alzheimer's disease: an event-related potential study. Neurobiol Aging 24:675-85
Sullivan, Edith V; Rosenbloom, Margaret J; Serventi, Kathleen L et al. (2003) Effects of alcohol dependence comorbidity and antipsychotic medication on volumes of the thalamus and pons in schizophrenia. Am J Psychiatry 160:1110-6
Deshmukh, Anjali; Rosenbloom, Margaret J; Pfefferbaum, Adolf et al. (2002) Clinical signs of cerebellar dysfunction in schizophrenia, alcoholism, and their comorbidity. Schizophr Res 57:281-91
Pfefferbaum, Adolf; Rosenbloom, Margaret; Serventi, Kathleen L et al. (2002) Corpus callosum, pons, and cortical white matter in alcoholic women. Alcohol Clin Exp Res 26:400-6
Alpert, Murray; Shaw, Richard J; Pouget, Enrique R et al. (2002) A comparison of clinical ratings with vocal acoustic measures of flat affect and alogia. J Psychiatr Res 36:347-53
Mathalon, Daniel H; Fedor, Mark; Faustman, William O et al. (2002) Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J Abnorm Psychol 111:22-41

Showing the most recent 10 out of 231 publications